nafronyl has been researched along with Glaucoma in 3 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Achache, F | 1 |
| Titzé, P | 1 |
| Movaffaghy, A | 1 |
| Mermoud, A | 3 |
| Faggioni, R | 2 |
| Van Melle, GD | 1 |
2 trials available for nafronyl and Glaucoma
| Article | Year |
|---|---|
[Treatment of normal pressure glaucoma with a serotonin S2 receptor antagonist, naftidrofuryl (praxilen)].
Topics: Aged; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pre | 1991 |
Double-blind study in the treatment of normal tension glaucoma with naftidrofuryl.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; | 1990 |
1 other study available for nafronyl and Glaucoma
| Article | Year |
|---|---|
[Effect of naftidrofuryl (praxilene) on optic nerve head blood flow in the patient with glaucoma].
Topics: Aged; Aged, 80 and over; Blood Flow Velocity; Blood Pressure; Dose-Response Relationship, Drug; Drug | 1999 |